Abbott Laboratories has filed a patent infringement suit against generic drug maker Teva Pharmaceuticals USA. The lawsuit is filed before the federal court in Wilmington, Delaware. The Patent is relating to Abbott’s AndroGel testosterone preparation bearing Patent number United States Patent 6,503,894. .In the complaint, Abbot has prayed before the Court to block U.S. sales of the drug by Teva until the patent expires in 2021.
To know more about the Intellectual Property services offered by Brain League please Click here
0 comments:
Post a Comment